Regulatory Headwinds Challenge Hims & Hers’ Growth Trajectory
Published on 11/17/2025 at 16:09 | Redaktion boerse-global.de
The telehealth sector faces increasing regulatory scrutiny, and Hims & Hers Health, Inc. is making strategic moves to navigate these complex waters. In a significant development, the company has appointed a former senior regulator to a key executive position amid growing pressure from health authorities.
Hims & Hers has named Deb Autor as its first Chief Policy Officer, a strategic hire that brings substantial regulatory expertise to the company’s leadership team. Autor previously served as deputy commissioner of the U.S. Food and Drug Administration and brings three decades of pharmaceutical industry experience, including recent tenure at AstraZeneca.
This appointment comes during a critical period for the telehealth Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
